Date of Presentation

5-4-2023 12:00 AM

College

School of Osteopathic Medicine

Poster Abstract

Canavan disease (CD) is an inherited leukodystrophy caused by inactivating mutations to the glial enzyme aspartoacylase (ASPA). ASPA catabolizes neuronal N-acetylaspartate (NAA) into free acetate and aspartate and loss of this function results in the chronic elevation of non-catabolized NAA and the failure of developmental myelination. Elevated NAA is thought to cause damage to myelin and myelin-producing cells (oligodendrocytes, but the viability of neurons in CD is relatively unexplored. We compare here the progressive degeneration of neurons in two regions of the CD mouse brain, the thalamus and the cortex, distinguished by differing degrees of vacuolation, and show that the relatively more affected thalamus is punctuated by significant neuron from 3 weeks of age onwards while cortical neurons appear relatively unaffected. Thalamic neuron loss is most acute at 3-6 weeks and mirrors parallel oligodendrocyte loss. Oligodendrocyte loss in the cortex during the same developmental window is comparable to the thalamus but is not associated with significant neuron loss. Both the thalamus and cortex present with elevated expression of Nat8L, the rate-limiting enzyme for NAA synthesis, but severe vacuolation is seen only in the thalamus, indicating the loss of glial ASPA is more directly linked to vacuolation than is elevated NAA alone.

Keywords

Canavan Disease, Hereditary Central Nervous System Demyelinating Diseases, Animal Disease Models, Thalamus, Nat8L

Disciplines

Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Disease Modeling | Genetic Processes | Laboratory and Basic Science Research | Medical Neurobiology | Medicine and Health Sciences | Nervous System Diseases | Neurology

Document Type

Poster

Share

COinS
 
May 4th, 12:00 AM

Differential Degeneration of Neurons in a Mouse Model of Canavan Disease

Canavan disease (CD) is an inherited leukodystrophy caused by inactivating mutations to the glial enzyme aspartoacylase (ASPA). ASPA catabolizes neuronal N-acetylaspartate (NAA) into free acetate and aspartate and loss of this function results in the chronic elevation of non-catabolized NAA and the failure of developmental myelination. Elevated NAA is thought to cause damage to myelin and myelin-producing cells (oligodendrocytes, but the viability of neurons in CD is relatively unexplored. We compare here the progressive degeneration of neurons in two regions of the CD mouse brain, the thalamus and the cortex, distinguished by differing degrees of vacuolation, and show that the relatively more affected thalamus is punctuated by significant neuron from 3 weeks of age onwards while cortical neurons appear relatively unaffected. Thalamic neuron loss is most acute at 3-6 weeks and mirrors parallel oligodendrocyte loss. Oligodendrocyte loss in the cortex during the same developmental window is comparable to the thalamus but is not associated with significant neuron loss. Both the thalamus and cortex present with elevated expression of Nat8L, the rate-limiting enzyme for NAA synthesis, but severe vacuolation is seen only in the thalamus, indicating the loss of glial ASPA is more directly linked to vacuolation than is elevated NAA alone.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.